Ebselen

Ebselen, synthetic drug for bipolar disorder and hearing loss, could help treat COVID-19: Study

The study, published in the open-access, peer-reviewed journal Science Advances, was conducted using state of the art computer simulations and no clinical trials have been done so far to prove the effects in coronavirus patients.